JD HEALTH
06618
BEKE-W
02423
JD-SW
09618
XIAOMI-W
01810
TRIP.COM-S
09961
(Q6)Oct 31, 2024 | (FY)Apr 30, 2024 | (Q6)Oct 31, 2023 | (FY)Apr 30, 2023 | (Q6)Oct 31, 2022 | (FY)Apr 30, 2022 | (Q6)Oct 31, 2021 | (FY)Apr 30, 2021 | (Q6)Oct 31, 2020 | (FY)Apr 30, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -5.10%-17.36M | ---- | -1,442.85%-16.52M | ---- | 17.03%1.23M | ---- | -94.59%1.05M | ---- | -20.90%19.42M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | 23.27%-376K | ---- | -48.48%-490K | ---- | -79.35%-330K | ---- | 38.87%-184K | ---- | -4,200.00%-301K |
Impairment and provisions: | ---- | -80.23%1.38M | ---- | 1,102.15%6.99M | ---- | 1.83%-697K | ---- | -117.80%-710K | ---- | 377.98%3.99M |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | --6.71M | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of trade receivables (reversal) | ---- | 402.18%1.38M | ---- | 139.45%275K | ---- | 44.15%-697K | ---- | -131.29%-1.25M | ---- | 377.98%3.99M |
-Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --538K | ---- | ---- |
Revaluation surplus: | ---- | 102.07%2.83M | ---- | -19.83%1.4M | ---- | 314.37%1.75M | ---- | 80.81%-814K | ---- | ---4.24M |
-Derivative financial instruments fair value (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --983K |
-Other fair value changes | ---- | 102.07%2.83M | ---- | -19.83%1.4M | ---- | 314.37%1.75M | ---- | 84.42%-814K | ---- | ---5.22M |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---20K | ---- | ---- | ---- | ---285K |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---20K | ---- | ---- | ---- | ---285K |
Depreciation and amortization: | ---- | 18.20%3.88M | ---- | -3.58%3.29M | ---- | 6.04%3.41M | ---- | 18.69%3.21M | ---- | 249.74%2.71M |
-Amortization of intangible assets | ---- | 0.06%1.64M | ---- | -0.06%1.63M | ---- | 34.02%1.64M | ---- | 269.70%1.22M | ---- | 2,438.46%330K |
Financial expense | ---- | -30.92%239K | ---- | 46.61%346K | ---- | -6.72%236K | ---- | 24.02%253K | ---- | 2,814.29%204K |
Special items | ---- | ---- | ---- | ---190K | ---- | ---- | ---- | ---- | ---- | ---- |
Operating profit before the change of operating capital | ---- | -81.49%-9.41M | ---- | -193.02%-5.18M | ---- | 98.33%5.57M | ---- | -86.93%2.81M | ---- | -10.03%21.49M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | -29.12%1.74M | ---- | 367.10%2.45M | ---- | 62.52%-918K | ---- | -215.25%-2.45M | ---- | 312.93%2.13M |
Accounts receivable (increase)decrease | ---- | 234.55%20.5M | ---- | -253.04%-15.24M | ---- | -69.34%9.96M | ---- | 281.71%32.47M | ---- | 23.12%-17.87M |
Accounts payable increase (decrease) | ---- | -482.22%-10M | ---- | 181.37%2.62M | ---- | 66.03%-3.22M | ---- | -2,768.18%-9.47M | ---- | -103.71%-330K |
Derivative financial instruments (increase) decrease | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---983K |
Special items for working capital changes | ---- | --313K | ---- | ---- | ---- | 370.77%176K | ---- | 87.92%-65K | ---- | -196.07%-538K |
Cash from business operations | ---- | 120.51%3.15M | ---- | -232.68%-15.35M | ---- | -50.35%11.57M | ---- | 498.25%23.3M | ---- | -57.18%3.9M |
Hong Kong profits tax paid | ---- | -179.02%-1.67M | ---- | 205.97%2.11M | ---- | 58.17%-1.99M | ---- | 21.02%-4.76M | ---- | -45.77%-6.03M |
China income tax paid | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 114.22%30K | ---- | 47.77%-211K |
Special items of business | 53.50%-10.87M | ---- | -278.00%-23.36M | ---- | -98.24%-6.18M | ---- | -124.21%-3.12M | ---- | 209.62%12.88M | ---- |
Net cash from operations | 53.50%-10.87M | 111.17%1.48M | -278.00%-23.36M | -238.24%-13.24M | -98.24%-6.18M | -48.42%9.58M | -124.21%-3.12M | 890.80%18.57M | 209.62%12.88M | -151.55%-2.35M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -95.77%15K | -23.27%376K | 112.57%355K | 48.48%490K | 1.21%167K | 79.35%330K | 725.00%165K | -38.87%184K | -79.59%20K | 4,200.00%301K |
Dividend received - investment | --18K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | --530K | ---- | ---- | ---- | --711K |
Purchase of fixed assets | 99.67%-13K | -15,684.62%-4.1M | -14,403.70%-3.92M | 98.12%-26K | 97.89%-27K | 26.54%-1.38M | 28.52%-1.28M | 35.03%-1.88M | 38.34%-1.79M | 81.35%-2.9M |
Purchase of intangible assets | ---- | ---- | ---800K | ---- | ---- | ---- | ---- | 84.05%-849K | -358.92%-849K | -89.20%-5.32M |
Recovery of cash from investments | ---- | --3.97M | ---- | ---- | ---- | ---- | ---- | -96.70%473K | ---- | --14.32M |
Cash on investment | ---- | ---- | ---- | ---- | ---- | -25.78%-10.5M | ---- | 32.39%-8.35M | -1,041.16%-7.87M | -257.86%-12.35M |
Net cash from investment operations | 100.46%20K | -48.92%237K | -3,215.00%-4.36M | 104.21%464K | 112.58%140K | -5.76%-11.02M | 89.39%-1.11M | -99.06%-10.42M | -253.71%-10.49M | 75.99%-5.24M |
Net cash before financing | 60.88%-10.85M | 113.43%1.72M | -358.95%-27.73M | -783.47%-12.78M | -42.78%-6.04M | -117.75%-1.45M | -277.33%-4.23M | 207.40%8.15M | 100.00%2.39M | 56.04%-7.58M |
Cash flow from financing activities | ||||||||||
New borrowing | ---- | ---- | ---- | --6.14M | --6.14M | ---- | ---- | --6.55M | --6.55M | ---- |
Refund | 87.57%-154K | 55.33%-2.29M | -73.29%-1.24M | -338.60%-5.14M | -53.76%-715K | ---1.17M | ---465K | ---- | ---- | ---- |
Interest paid - financing | -12.62%-116K | 30.92%-239K | 44.62%-103K | -46.61%-346K | -48.80%-186K | 6.72%-236K | -0.81%-125K | -24.02%-253K | -37.78%-124K | -2,814.29%-204K |
Net cash from financing operations | 41.65%-783K | -797.91%-3.01M | -126.17%-1.34M | 126.31%431K | 830.48%5.13M | -129.62%-1.64M | -112.02%-702K | 488.07%5.53M | 1,017.92%5.84M | -290.41%-1.43M |
Effect of rate | 426.32%100K | -211.03%-443K | -96.72%19K | 278.13%399K | 19,200.00%579K | -134.84%-224K | -99.00%3K | 1,386.00%643K | 199.67%301K | 94.33%-50K |
Net Cash | 60.00%-11.63M | 89.53%-1.29M | -3,083.68%-29.07M | -300.26%-12.34M | 81.49%-913K | -122.55%-3.08M | -159.98%-4.93M | 251.79%13.68M | 1,376.48%8.22M | 48.86%-9.01M |
Begining period cash | -5.08%32.43M | -25.91%34.17M | -25.91%34.17M | -6.69%46.11M | -6.69%46.11M | 40.79%49.42M | 40.79%49.42M | -20.51%35.1M | -20.51%35.1M | -29.52%44.16M |
Cash at the end | 308.48%20.9M | -5.08%32.43M | -88.82%5.12M | -25.91%34.17M | 2.90%45.78M | -6.69%46.11M | 1.98%44.49M | 40.79%49.42M | -1.78%43.63M | -20.51%35.1M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Debo Certified Public Accountants Limited | -- | Debo Certified Public Accountants Limited | -- | Debo Certified Public Accountants Limited | -- | Debo Certified Public Accountants Limited | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.